Search results
1 company and 5 research reports found for "Epigenomics AG"
Company results
- Epigenomics AG
Epigenomics is a German molecular diagnostics company focused on early detection of cancer. Its main...
Sector reports
No sector reports have been found.
Research results
Epigenomics AG
US results in sight
Update | Pharmaceutical & Healthcare | 24/11/2011The results of an 8,000-patient trial of Epigenomics’ blood-based colorectal cancer diagnostic, Epi proColon, should be reported shortly. If pos...
Epigenomics AG
Cleared for takeoff
Outlook | Pharmaceutical & Healthcare | 30/06/2011Epi proColon, Epigenomics’ colorectal cancer test, offers patients a simple and convenient alternative to current screening methods, and its app...
Epigenomics AG
Positiver Ausblick
QuickView | Pharmaceutical & Healthcare | 10/03/2010PRESEPT study issues have been resolved by sample retesting. The reasons for the outlier results have not been disclosed. The academic steering group ...
Epigenomics AG
Es ist zu hell
QuickView | Pharmaceutical & Healthcare | 08/02/2010A possible cause for the variable PRESEPT laboratory data was identified as too much background fluorescence in a PCR system. Reanalysis of samples sh...
Epigenomics AG
Probleme in den Daten
QuickView | Pharmaceutical & Healthcare | 20/01/2010Initial data from the PRESEPT study on the bowel cancer test, Sept9, were released on 15 January. One laboratory had a lower detection rate than the o...
